The FDA’s Weak Drug Manufacturing Oversight Is A Potentially Deadly Problem
Though drug recalls are relatively uncommon in the U.S., reduced inspections increase the likelihood of manufacturing errors that slip through the cracks.
Read Original Article: The FDA’s Weak Drug Manufacturing Oversight Is A Potentially Deadly Problem »
